Clinical trials: Limited Stage Small Cell Lung Carcinoma
Non-small Cell Lung Cancer
The Recurrence Gene Profiles of Adjuvant Osimertinib Therapy in Resected Non-Small-Cell Lung Cancer
This study was a multicenter, real-world observational study aimed at characterizing the genomic landscape of recurrence in patients with EGFR-sensitizing mutation-positive early-stage (clinical stage IB-IIIA) non-small cell lung…
- Trial name
- RAISE (NCT06477055)
- Where
- 2 sites in China
- Volunteers
- 43 people
- Sponsor
- Hunan Province Tumor Hospital
Non-Small Cell Lung Cancer, Electroacupuncture
Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer
Postoperative immunoadjuvant therapy has been proven to significantly reduce the risk of recurrence after resectable NSCLC, and has become a new standard of postoperative adjuvant therapy for stage II-III NSCLC.
- Conditions
- Non-Small Cell Lung Cancer, Electroacupuncture, Immune Checkpoint Inhibitors
- Trial name
- NCT07034326
- Testing
- Electroacupuncture combined with immunotherapy, Zilongjin tablet combined with immunotherapy, Immunotherapy
- Where
- China
- Volunteers
- 405 people
- Sponsor
- Kong Fanming
SCLC, Limited Stage
Durvalumab Combined With Chemoradiotherapy for Limited Stage Small Cell Lung Cancer (Camel-01)
This trial aims to assess efficacy and safety of durvalumab combined with chemoradiotherapy for limited stage small cell lung cancer.
- Trial name
- NCT06371482
- Testing
- Durvalumab, Chemotherapy drug of EP regimen, radiotherapy
- Where
- China
- Volunteers
- 58 people
- Sponsor
- Hebei Medical University Fourth Hospital